Joint Graduate Group in Bioengineering, University of California at San Francisco and Berkeley, San Francisco, California 94143, USA.
Bioconjug Chem. 2010 May 19;21(5):892-902. doi: 10.1021/bc900448f.
Metal chelation-ligand interactions, such as occur between nitrilotriacetic acid (NTA)-nickel and multihistidines, enable the noncovalent attachment of histidine-modified proteins to liposomes and other particles. We compared three lipids: a mono-NTA lipid (ca. 10 microM affinity) and two tris-NTA lipid derivatives (ca. 3 nM and 0.2 nM affinity) in their ability to retain two different his(6)-containing proteins on NTA-liposomes in the presence of serum or plasma and after intravenous injection in mice. At nanomolar affinities, the off-rate of a his(6)-ligand is sufficiently long so that his(6)-proteins attached to particle surfaces will remain with the particle for hours; thus, we hypothesized that the increased his(6) affinity of multivalent NTA-modified liposomes would retain his(6)-proteins longer both in vitro and in vivo. For each of the three lipids, we found a robust association and complete activity retention of two his(6)-modified proteins: a far red-fluorescent protein, monomeric Katushka (mKate), and a prodrug-converting enzyme, yeast cytosine deaminase (yCD). Proteins associated more tightly in vitro with tris-NTA liposomes than with mono-NTA liposomes in the presence of refiltered fetal calf serum and mouse plasma. Free yCD exchanged with previously associated mKate for tris-NTA binding sites on the liposome surface. This exchange was due to the exchange of the proteins for NTA occupancy and not due to the exchange of tris-NTA lipid out of the liposome. The amount of yCD on the surface was similar if the proteins were co-associated or if mKate was pre-associated. This exchange confirms that NTA associated proteins are in a dynamic state and can exchange with multihistidine proteins in the biological milieu. There was no difference in circulation time of the protein when it was intravenously administered by itself or attached to any of the NTA-modified liposomes because in vivo the protein was rapidly released from the NTA liposomes. Upon recovery from blood, liposomes containing tris-NTA accumulated a different plasma protein profile than control liposomes, suggesting that Ni-NTA specifically interacts with some plasma proteins. The reason for the rapid protein dissociation from the liposome in vivo is not clear; it could be due to displacement by endogenous histidine-containing proteins or to natural chelators that remove nickel from the NTA. Regardless of the cause, improvements in chelator or ligand design are needed before metal chelation will be capable of retaining histidine-modified proteins on NTA liposomes after in vivo administration.
金属螯合配体相互作用,如三氮三乙酸(NTA)-镍和多组氨酸之间发生的相互作用,使组氨酸修饰蛋白能够非共价附着到脂质体和其他颗粒上。我们比较了三种脂质:一种单-NTA 脂质(约 10 μM 亲和力)和两种三-NTA 脂质衍生物(约 3 nM 和 0.2 nM 亲和力),以研究它们在存在血清或血浆的情况下以及在小鼠静脉注射后,保留 NTA-脂质体上两种不同的含 His6 的蛋白质的能力。在纳摩尔亲和力下,His6 配体的失活速率足够长,以至于附着在颗粒表面的 His6 蛋白将在数小时内保留在颗粒上;因此,我们假设多价 NTA 修饰的脂质体增加的 His6 亲和力将在体外和体内都能更长时间地保留 His6 修饰蛋白。对于这三种脂质,我们发现两种 His6 修饰蛋白的结合牢固且完全保留:一种远红荧光蛋白单体 Katushka(mKate)和一种前药转化酶酵母胞嘧啶脱氨酶(yCD)。在经过再过滤的胎牛血清和小鼠血浆中,与单-NTA 脂质体相比,His6 修饰蛋白与三-NTA 脂质体的结合更紧密。游离的 yCD 与先前结合的 mKate 交换,以占据脂质体表面的三-NTA 结合位点。这种交换是由于蛋白质与 NTA 结合,而不是由于三-NTA 脂质从脂质体中交换出去。如果蛋白质同时结合或 mKate 预先结合,则表面上的 yCD 量相似。这种交换证实,与 NTA 结合的蛋白质处于动态状态,并且可以在生物环境中与多组氨酸蛋白交换。当它单独静脉内给药或附着于任何 NTA 修饰的脂质体时,蛋白质的循环时间没有差异,因为在体内,蛋白质从 NTA 脂质体中迅速释放。从血液中回收后,含有三-NTA 的脂质体积累了不同的血浆蛋白谱,这表明 Ni-NTA 特异性地与一些血浆蛋白相互作用。蛋白质在体内从脂质体中快速解离的原因尚不清楚;它可能是由于内源性含组氨酸蛋白的置换,或由于天然螯合剂从 NTA 中去除镍。无论原因是什么,在体内给药后,金属螯合都能够保留 His6 修饰蛋白之前,都需要改进螯合剂或配体设计。